Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...

The stock's fall snapped a four-day winning streak.

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

Morgan Stanley’s stock (NYSE: MS) gained over 30% year-to-date. This compares to rival Goldman Sachs stock, which has seen its stock gain over 40% year-to-date. So what are some of the trends ...

Morgan Stanley has teamed up with cross-border money transmitter Wise to settle foreign-exchange payments for the investment ...

Nvidia’s (NASDAQ:NVDA) seemingly never-ending surge has been more muted in recent times. While sentiment has far from soured ...

A portfolio of Brightview Senior Living communities spanning four markets, including Philadelphia, has sold to one of America ...